Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological stimulation of sigma-1 receptor promotes activation of astrocyte via ERK1/2 and GSK3β signaling pathway
Yun Wang, Hua‐Feng Jiang, Jing Ni, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2019) Vol. 392, Iss. 7, pp. 801-812
Closed Access | Times Cited: 16

Showing 16 citing articles:

Plasma exosomes from depression ameliorate inflammation-induced depressive-like behaviors via sigma-1 receptor delivery
Yun Wang, Ce Gao, Tianyu Gao, et al.
Brain Behavior and Immunity (2021) Vol. 94, pp. 225-234
Closed Access | Times Cited: 57
Sigma-1 receptor: A potential target for the development of antidepressants
Yuming Wang, Cong‐Yuan Xia, Hongmei Jia, et al.
Neurochemistry International (2022) Vol. 159, pp. 105390-105390
Closed Access | Times Cited: 40
Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders
Kinga Sałaciak, Karolina Pytka
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 1114-1136
Open Access | Times Cited: 47
Sarsasapogenin restores podocyte autophagy in diabetic nephropathy by targeting GSK3β signaling pathway
Xizhi Li, Hong Jiang, Xu Liu, et al.
Biochemical Pharmacology (2021) Vol. 192, pp. 114675-114675
Closed Access | Times Cited: 38
Emerging Benefits: Pathophysiological Functions and Target Drugs of the Sigma-1 Receptor in Neurodegenerative Diseases
Ning‐hua Wu, Yu Ye, Bin-bin Wan, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 11, pp. 5649-5666
Closed Access | Times Cited: 35
Hesperetin ameliorates diabetes-associated anxiety and depression-like behaviors in rats via activating Nrf2/ARE pathway
Xia Zhu, Yumeng Zhang, Mengya Zhang, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 7, pp. 1969-1983
Closed Access | Times Cited: 32
Chaperone Sigma1R and Antidepressant Effect
М. В. Воронин, Yulia V. Vakhitova, С. Б. Середенин
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7088-7088
Open Access | Times Cited: 30
Activation of astrocytic sigma‐1 receptor exerts antidepressant‐like effect via facilitating CD38‐driven mitochondria transfer
Yun Wang, Jing Ni, Tianyu Gao, et al.
Glia (2020) Vol. 68, Iss. 11, pp. 2415-2426
Closed Access | Times Cited: 28
Sarsasapogenin ameliorates diabetes‐associated memory impairment and neuroinflammation through down‐regulation of PAR‐1 receptor
Li Kong, Yue Liu, Yu‐Meng Zhang, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 6, pp. 3167-3180
Closed Access | Times Cited: 14
Stimulation of astrocytic sigma-1 receptor is sufficient to ameliorate inflammation- induced depression
Lin Guo, Tianyu Gao, Ce Gao, et al.
Behavioural Brain Research (2021) Vol. 410, pp. 113344-113344
Closed Access | Times Cited: 13
A Selective M1 and M3 Receptor Antagonist, Penehyclidine Hydrochloride, Exerts Antidepressant-Like Effect in Mice
Xiaojing Sun, Congcong Sun, Lingyan Zhai, et al.
Neurochemical Research (2019) Vol. 44, Iss. 12, pp. 2723-2732
Closed Access | Times Cited: 12
The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies
Zhen Xuen Brandon Low, Wei Shen Ng, Eugene Lim, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024), pp. 111139-111139
Open Access | Times Cited: 1
Long-Lasting Nociplastic Pain Modulation by Repeated Administration of Sigma-1 Receptor Antagonist BD1063 in Fibromyalgia-like Mouse Models
Beltrán Álvarez-Pérez, Anna Bagó‐Mas, Meritxell Deulofeu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11933-11933
Open Access | Times Cited: 6
Repurposing fluoxetine to treat lymphocytic leukemia: Apoptosis induction, sigma-1 receptor upregulation, inhibition of IL-2 cytokine production, and autophagy induction
Chanichon Chomchoei, James Michael Brimson, Sirikalaya Brimson
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 12, pp. 1087-1097
Closed Access | Times Cited: 6
Sigma 1 Receptor Modulates Optic Nerve Head Astrocyte Reactivity
Jing Zhao, Graydon B. Gonsalvez, Manuela Bartoli, et al.
Investigative Ophthalmology & Visual Science (2021) Vol. 62, Iss. 7, pp. 5-5
Open Access | Times Cited: 7
Analysis of Sigma-1 Receptor Antagonist BD1047 Effect on Upregulating Proteins in HIV-1-Infected Macrophages Exposed to Cocaine Using Quantitative Proteomics
Omar Vélez-López, Kelvin Carrasquillo, Yadira M. Cantres-Rosario, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 1934-1934
Open Access
Page 1

Scroll to top